Suppression of Tumorigenicity 12 (ST12)

Suppression of Tumorigenicity 12, also known as prostate adenocarcinoma, is related to adenocarcinoma and prostate cancer. An important gene associated with Suppression of Tumorigenicity 12 is KLF6 (KLF Transcription Factor 6), and among its related pathways/superpathways are Gene expression (Transcription) and Infectious disease. The drugs Prilocaine and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include prostate and lymph node, and related phenotypes are Decreased viability and Increased cell migration